Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Diagnostics 2018: Steady Progress And The Big Get Bigger

Jan 21 2018

• By Mark Ratner

Related Content

M&A Analysis: Grail's Chinese Merger Wraps Up Busy May

Jun 09 2017

PerkinElmer Solidifies OUS Presence With $1.3bn EUROIMMUN Buy

Jun 19 2017

Podcast: Thermo Fisher Talks Regulatory Experience With Oncomine

Jul 06 2017

US FDA Implements 'Firm-Based' Regulatory Approach To DTC Genetic Health Risk Tests

Nov 07 2017

A New York Minute: US FDA Leverages State's Health Department To Expedite NGS Reviews

Nov 15 2017

HHS Nominee Azar And The Taint Of Industry

Dec 06 2017

Diagnostics In 2016: From Alere To Zika

Jan 25 2017

First Expedited NGS Test Breaks Through FDA Review

Dec 01 2017

Related Companies

23andMe, Inc.

Memorial Sloan Kettering Cancer Center

Foundation Medicine, Inc.

Thermo Fisher Scientific

Novartis AG

Pfizer Inc.

AstraZeneca PLC

Konica Minolta, Inc.

Ambry Genetics

Revvity Inc.

EUROIMMUN Medizinische Labordiagnostika AG

Abbott

Alere, Inc.

GRAIL Inc.

Karius, Inc.

Verily

DexCom, Inc.

Roche Holding AG

mySugr GmbH

Medtronic plc

Additional Topics

Market Access Regulation Medical Device Diagnostics

More from Market Access

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window